University of Alabama Birmingham-Developed Viral Immunotherapy for Pediatric Brain Tumors Shows Promise
April 12, 2021
April 12, 2021
BIRMINGHAM, Alabama, April 12 (TNSRes) -- The University of Alabama issued the following news:
A modified herpes virus, alone and in combination with radiation, has been shown to be well tolerated with early signs of clinical effectiveness in pediatric patients with high-grade brain tumors, or gliomas, according to findings from researchers at the University of Alabama at Birmingham and Children's of Alabama. The findings were presented at the virtual American Association for C . . .
A modified herpes virus, alone and in combination with radiation, has been shown to be well tolerated with early signs of clinical effectiveness in pediatric patients with high-grade brain tumors, or gliomas, according to findings from researchers at the University of Alabama at Birmingham and Children's of Alabama. The findings were presented at the virtual American Association for C . . .